Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
PhotoCure |
---|---|
Information provided by: | PhotoCure |
ClinicalTrials.gov Identifier: | NCT00594425 |
This multicenter study will be divided into 2 phases. The first phase will be an open label, dose-escalation phase, while the second will be a blinded, randomized, vehicle-controlled, parallel-group, dose-response phase. The second phase will only start if the first phase succeeds in establishing well tolerated dose(s). Patients with moderate to severe acne vulgaris in the face will be included.
Condition | Intervention | Phase |
---|---|---|
Acne Vulgaris |
Drug: Methyl aminolevulinate (MAL) PDT |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 190 |
Study Start Date: | February 2007 |
Estimated Study Completion Date: | August 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
PDT using MAL concentration A
|
Drug: Methyl aminolevulinate (MAL) PDT
Cream application followed by illumination with red light
|
2: Experimental
PDT using MAL concentration B
|
Drug: Methyl aminolevulinate (MAL) PDT
Cream application followed by illumination with red light
|
3: Placebo Comparator
PDT using Placebo cream
|
Drug: Methyl aminolevulinate (MAL) PDT
Cream application followed by illumination with red light
|
Ages Eligible for Study: | 15 Years to 40 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Photocure ( Sylvia Vetrhus, Clinical Trial Manager ) |
Study ID Numbers: | PC TA202B/06 |
Study First Received: | January 3, 2008 |
Last Updated: | August 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00594425 |
Health Authority: | United States: Food and Drug Administration |
Exanthema Facial Dermatoses Facies Skin Diseases |
Methyl 5-aminolevulinate Sebaceous Gland Diseases Acne Vulgaris Aminolevulinic Acid |
Photosensitizing Agents Radiation-Sensitizing Agents Acneiform Eruptions Therapeutic Uses |
Physiological Effects of Drugs Dermatologic Agents Pharmacologic Actions |